Found: 25
Select item for more details and to access through your institution.
Lenalidomide in Combination with Dexamethasone in Elderly Patients with Advanced, Relapsed or Refractory Multiple Myeloma and Renal Failure.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2013, v. 5, n. 1, p. 1, doi. 10.4084/MJHID.2013.037
- By:
- Publication type:
- Article
Genetic lesions associated with blastic transformation of polycythemia vera and essential thrombocythemia.
- Published in:
- Genes, Chromosomes & Cancer, 1997, v. 19, n. 4, p. 250, doi. 10.1002/(SICI)1098-2264(199708)19:4<250::AID-GCC7>3.0.CO;2-W
- By:
- Publication type:
- Article
Relief of intractable pruritus in polycythemia vera with recombinant interferon alfa.
- Published in:
- American Journal of Hematology, 1993, v. 43, n. 4, p. 316, doi. 10.1002/ajh.2830430419
- By:
- Publication type:
- Article
P-164: Safety of lenalidomide (LEN)-based therapy vs non–LEN-based therapy for transplant-ineligible newly diagnosed multiple myeloma (TNE NDMM): update from the post-authorization study MM-034.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S125, doi. 10.1016/S2152-2650(21)02291-6
- By:
- Publication type:
- Article
OAB-055: Gain and amplification of 1q induce transcriptome deregulation and worsen the outcome of newly diagnosed Multiple Myeloma patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S34, doi. 10.1016/S2152-2650(21)02127-3
- By:
- Publication type:
- Article
A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Real-World Evidence of the Use of Carfilzomib and Dexamethasone According to Age Subgroup: An Interim Analysis From a Prospective Observational Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e282, doi. 10.1016/j.clml.2019.09.465
- By:
- Publication type:
- Article
Real-World Use of Carfilzomib Therapy Among Patients With Existing Cardiovascular Medical History: An Analysis of a Prospective Observational Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e281, doi. 10.1016/j.clml.2019.09.464
- By:
- Publication type:
- Article
European Post-Authorization Safety Study of Patients With Relapsed or Refractory Multiple Myeloma Treated With Pomalidomide in a Real-World Setting.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e256, doi. 10.1016/j.clml.2019.09.423
- By:
- Publication type:
- Article
Post-Authorization Safety Study of Lenalidomide-Based vs Non–Lenalidomide-Based Treatment in Transplant-Ineligible Newly Diagnosed Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e226, doi. 10.1016/j.clml.2019.09.376
- By:
- Publication type:
- Article
Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Heavy+Light Chain and Free Light Chain Assays at Baseline and During Follow-up in EMN02/HO95 Multiple Myeloma Clinical Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e47, doi. 10.1016/j.clml.2017.03.084
- By:
- Publication type:
- Article
European Post-Approval Safety Study (EU Pass) of Relapsed/Refractory Multiple Myeloma (RRMM): Safety, Including Second Primary Malignancies, in a Large Cohort of Patients (Pts) Treated With Lenalidomide (LEN), Thalidomide (THAL), and Bortezomib (BORT).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e65, doi. 10.1016/j.clml.2017.03.118
- By:
- Publication type:
- Article
Phase 2 Multicenter Study of Pomalidomide (POM) Plus Low-Dose Dexamethasone (LoDEX) in Patients (Pts) With Relapsed/Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI): An Updated Safety Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e145, doi. 10.1016/j.clml.2017.03.261
- By:
- Publication type:
- Article
Belantamab mafodotin in triple‐refractory multiple myeloma patients: A retro‐prospective observational study in Italy.
- Published in:
- EJHaem, 2024, v. 5, n. 3, p. 485, doi. 10.1002/jha2.907
- By:
- Publication type:
- Article
Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1182971
- By:
- Publication type:
- Article
Synergistic cytotoxicity of AZT plus alpha and gamma interferon in chronic myeloid leukemia cell line K562.
- Published in:
- European Journal of Haematology, 1993, v. 51, n. 4, p. 209, doi. 10.1111/j.1600-0609.1993.tb00632.x
- By:
- Publication type:
- Article
Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe).
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 5, p. 712, doi. 10.1007/s00259-017-3909-8
- By:
- Publication type:
- Article
Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe).
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 3, p. 414, doi. 10.1007/s00259-015-3200-9
- By:
- Publication type:
- Article
SEN6, a locus for SV40-mediated immortalization of human cells, maps to 6q26-27.
- Published in:
- Oncogene, 1997, v. 14, n. 3, p. 313, doi. 10.1038/sj.onc.1200842
- By:
- Publication type:
- Article
Expression and functional role of c-kit ligand (SCF) in human multiple myeloma cells.
- Published in:
- British Journal of Haematology, 1994, v. 88, n. 4, p. 760, doi. 10.1111/j.1365-2141.1994.tb05115.x
- By:
- Publication type:
- Article
ALL-TRANS RETINOIC ACID IMPROVES ERYTHROPOIESIS IN MYELODYSPLASTIC SYNDROMES: A CASE REPORT.
- Published in:
- British Journal of Haematology, 1992, v. 81, n. 3, p. 444, doi. 10.1111/j.1365-2141.1992.tb08254.x
- By:
- Publication type:
- Article
STEROID-RESISTANT ACQUIRED PURE RED CELL APLASIA: A PARTIAL REMISSION INDUCED BY RECOMBINANT HUMAN ERYTHROPOIETIN.
- Published in:
- British Journal of Haematology, 1991, v. 79, n. 1, p. 125, doi. 10.1111/j.1365-2141.1991.tb08023.x
- By:
- Publication type:
- Article
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma.
- Published in:
- 2017
- By:
- Publication type:
- journal article